Austin Greenall
Sales Director @Celestra Health Systems
Signup · Get unlimited contacts
WORK HISTORY
Sales Director @Celestra Health Systems
Ottawa, ON, CA
Responsible for global sales BD and clinical partnerships for Celestra Health’s FDA-designated Class II “Gait Lab in a Shoe,” a novel digital biomarker platform that combines smart insoles, AI, and the world’s largest free-living gait database to transform how progression in MS and Parkinson’s disease is measured.Key responsibilities include- Developing and executing global sales and commercialization strategy- Driving client engagement with pharmaceutical, healthcare, and rehabilitation leaders- Building partnerships to integrate Celestra’s platform into clinical trials and care delivery- Creating ROI models and value frameworks that demonstrate impact for patients, clinicians, and payers- Supporting clinical collaborations to validate sensitivity, accuracy, and scalability of outcomes measurementFocused on expanding market reach and adoption by aligning breakthrough hardware and AI innovation with clinical practice, evidence development, and the needs of pharma and healthcare systems worldwide.
EDUCATION
University of Ottawa
HBSc, Biopharmaceutical Sciences - Genomics & Medicinal Chemistry
SKILLS
ABOUT AUSTIN GREENALL
With over eighteen years of experience in sales and business development, I have built a proven track record of creating and executing strategic growth plans, building and maintaining partnerships, and expanding revenue streams across biotechnology, digital health, and regulated medical products. My career has focused on bringing innovative, evidence-based technologies to market and aligning them with the needs of patients, clinicians, and healthcare systems worldwide. I am now proud to serve as Sales Director at Celestra Health Systems, where we are pioneering the FDA-designated Class II “Gait Lab in a Shoe.” This novel digital biomarker platform combines smart insoles, AI, and the world’s largest free-living gait database to provide earlier and more sensitive measurement of mobility changes in MS and Parkinson’s disease. My role focuses on global commercialization, strategic partnerships with pharma and healthcare leaders, and driving adoption of technology that improves the accuracy and impact of neurological disease measurement. Previously, I directed sales and business development for OBS Medical and Therapeutic Monitoring Systems (TMS), where I championed the commercialization of AI-driven clinical decision support solutions including the Visensia Safety Index, Extubation Advisor, and Sepsis Advisor. These roles gave me deep experience in predictive analytics, hospital sales, ROI modeling, and integration of digital health tools into complex ICU and ward environments. Earlier in my career, as VP of Sales & Business Development at PURPLEFARM, I led corporate development and retail sales across Canada, building strong relationships with provincial boards, retailers, and industry partners while driving product development and to-market strategy. Before that, as Director of Business Development at DNA Genotek, I was integral to the assessment and acquisition of Novosanis and Core Biome, two innovators in molecular sampling and microbiome analysis. I specialize in- Global Sales & Business Development - Digital Health & Predictive Analytics - Clinical Decision Support & Biomarker Commercialization - Market Research & Financial Analysis - Strategic Partnerships & Negotiation I am passionate about advancing healthcare innovation, working at the intersection of science, technology, and patient outcomes, and collaborating with industry leaders across biotechnology, digital health, and pharmaceuticals.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.